SOFT TISSUE SARCOMA ADULT
Clinical trials for SOFT TISSUE SARCOMA ADULT explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA ADULT trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise against rare cancers
Disease control CompletedThis study tested a combination of two drugs, lenvatinib and eribulin, in 30 adults with advanced sarcoma (a type of cancer) that could not be removed by surgery or had spread. The goal was to see if the combo could shrink tumors or stop them from growing. Participants had alread…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE1, PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated May 17, 2026 02:44 UTC
-
Immunotherapy duo shows promise in rare cancer trial
Disease control CompletedThis study tested a combination of two immunotherapy drugs, nivolumab and relatlimab, in 68 adults with advanced soft-tissue sarcoma. The goal was to see if the combo could shrink tumors or stop them from growing for at least 6 months. Participants had a specific immune feature i…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Scientists hunt for clues to predict sarcoma drug success
Knowledge-focused CompletedThis study aimed to find biological markers that could predict how well the drug trabectedin works in people with certain advanced soft-tissue sarcomas. Researchers collected tumor samples and blood from 29 adults before and during treatment to look for patterns. The goal was to …
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC